Skip to main content

Trileptal News

Prenatal Valproate Exposure Tied to Psychiatric Disorders in Late Childhood

WEDNESDAY, May 24, 2023 – Prenatal exposure to the antiepileptic medication valproate is associated with an increased risk for later psychiatric disorders among children of mothers with epilepsy,...

FDA Medwatch Alert: Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall - Mislabeled Packaging

ISSUE: American Health Packaging (AHP) voluntarily recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation that may contain individual...

FDA Medwatch Alert: Antiepileptic Drugs

[UPDATE 05/05/2009] FDA notified healthcare professionals that it approved updated labeling for antiepileptic drugs used to treat epilepsy, psychiatric disorders, and other conditions (e.g., migraine...

FDA Medwatch Alert: Trileptal (oxcarbazepine) Tablets and Oral Solution

Novartis Pharmaceuticals and FDA notified healthcare professionals about revisions to the WARNINGS and PRECAUTIONS sections of the prescribing information for TRILEPTAL (oxcarbazepine) tablets and...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Seizures, Epilepsy

Trileptal patient information at Drugs.com